Clinical Trial Update: A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the study medicine Ritlecitinib in adults with hidradenitis suppurativa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: RECRUITING